Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$519.88
10.222.01%
al cierre: -
$519.88
0.000.00%
After hour: Oct 31, 4:03 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Ulta Beauty Inc ha un obiettivo di prezzo di consenso pari a $544.83, stabilito in base alle ultime valutazioni degli analisti di 26. Le ultime 3 valutazioni degli analisti sono state rilasciate da Telsey Advisory Group, Wells Fargo y Canaccord Genuity il octubre 17, 2025, octubre 16, 2025 y octubre 10, 2025. Con un obiettivo di prezzo medio di $571 tra le Telsey Advisory Group, Wells Fargo y Canaccord Genuity, c'è un implicito 9.83% upside per Ulta Beauty Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Telsey Advisory Group
Wells Fargo
Canaccord Genuity
Piper Sandler
Barclays
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Ulta Beauty
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/17/2025 | 17.33% | Telsey Advisory Group | $610 → $610 | Maintains | Outperform | |||
10/16/2025 | -13.44% | Wells Fargo | $425 → $450 | Maintains | Underweight | |||
10/10/2025 | 25.61% | Canaccord Genuity | $650 → $653 | Maintains | Buy | |||
09/25/2025 | — | Argus Research | — | Upgrade | Hold → Buy | |||
09/08/2025 | 17.33% | Telsey Advisory Group | $610 → $610 | Maintains | Outperform | |||
09/04/2025 | 13.49% | Piper Sandler | → $590 | Assumes | → Overweight | |||
09/02/2025 | 18.68% | Barclays | $589 → $617 | Maintains | Overweight | |||
08/29/2025 | 20.22% | DA Davidson | $585 → $625 | Maintains | Buy | |||
08/29/2025 | 25.03% | Canaccord Genuity | $630 → $650 | Maintains | Buy | |||
08/29/2025 | 12.33% | Goldman Sachs | $530 → $584 | Maintains | Buy | |||
08/29/2025 | 15.41% | Morgan Stanley | $550 → $600 | Maintains | Overweight | |||
08/29/2025 | 30.8% | UBS | $640 → $680 | Maintains | Buy | |||
08/29/2025 | -18.25% | Wells Fargo | $400 → $425 | Maintains | Underweight | |||
08/29/2025 | 16.37% | Raymond James | $580 → $605 | Reiterates | Outperform → Outperform | |||
08/29/2025 | 23.11% | Evercore ISI Group | $595 → $640 | Maintains | Outperform | |||
08/29/2025 | 17.33% | Telsey Advisory Group | $590 → $610 | Maintains | Outperform | |||
08/29/2025 | 10.6% | B of A Securities | $500 → $575 | Maintains | Neutral | |||
08/29/2025 | 15.41% | Baird | $575 → $600 | Maintains | Outperform | |||
08/26/2025 | 21.18% | Canaccord Genuity | $600 → $630 | Maintains | Buy | |||
08/26/2025 | 5.79% | Jefferies | $425 → $550 | Maintains | Hold | |||
08/25/2025 | 13.49% | Telsey Advisory Group | $520 → $590 | Maintains | Outperform | |||
08/22/2025 | 15.41% | JP Morgan | $525 → $600 | Maintains | Overweight | |||
08/22/2025 | 13.3% | Barclays | $518 → $589 | Upgrade | Equal-Weight → Overweight | |||
08/21/2025 | 23.11% | UBS | $525 → $640 | Maintains | Buy | |||
08/18/2025 | 5.79% | Citigroup | $450 → $550 | Maintains | Neutral | |||
08/15/2025 | -23.06% | Wells Fargo | $350 → $400 | Maintains | Underweight | |||
08/12/2025 | 15.41% | Oppenheimer | $510 → $600 | Maintains | Outperform | |||
08/06/2025 | -0.36% | Barclays | $485 → $518 | Maintains | Equal-Weight | |||
08/01/2025 | 15.41% | Canaccord Genuity | $542 → $600 | Maintains | Buy | |||
07/31/2025 | 12.53% | DA Davidson | $550 → $585 | Maintains | Buy | |||
07/25/2025 | -1.9% | Loop Capital | $510 → $510 | Downgrade | Buy → Hold | |||
07/11/2025 | 0.02% | Telsey Advisory Group | $520 → $520 | Maintains | Outperform | |||
07/07/2025 | 5.79% | DA Davidson | $485 → $550 | Maintains | Buy | |||
06/26/2025 | 0.02% | Telsey Advisory Group | $520 → $520 | Maintains | Outperform | |||
06/16/2025 | -1.9% | Loop Capital | $480 → $510 | Maintains | Buy | |||
06/02/2025 | -6.71% | Barclays | $327 → $485 | Maintains | Equal-Weight | |||
05/30/2025 | 5.79% | Morgan Stanley | $460 → $550 | Maintains | Overweight | |||
05/30/2025 | -13.44% | Citigroup | $425 → $450 | Maintains | Neutral | |||
05/30/2025 | -1.9% | Oppenheimer | $465 → $510 | Maintains | Outperform | |||
05/30/2025 | 0.98% | Baird | $440 → $525 | Maintains | Outperform | |||
05/30/2025 | -3.82% | Raymond James | $450 → $500 | Reiterates | Outperform → Outperform | |||
05/30/2025 | -5.75% | Evercore ISI Group | $465 → $490 | Maintains | Outperform | |||
05/30/2025 | -15.94% | Piper Sandler | $386 → $437 | Reiterates | Neutral → Neutral | |||
05/30/2025 | 0.98% | JP Morgan | $477 → $525 | Maintains | Overweight | |||
05/30/2025 | -6.71% | DA Davidson | $415 → $485 | Maintains | Buy | |||
05/30/2025 | 4.25% | Canaccord Genuity | $510 → $542 | Maintains | Buy | |||
05/30/2025 | 0.98% | UBS | $490 → $525 | Maintains | Buy | |||
05/30/2025 | -32.68% | Wells Fargo | $315 → $350 | Maintains | Underweight | |||
05/30/2025 | 0.02% | Telsey Advisory Group | $460 → $520 | Maintains | Outperform | |||
05/23/2025 | -18.25% | Citigroup | $365 → $425 | Maintains | Neutral | |||
05/23/2025 | -8.25% | JP Morgan | $475 → $477 | Maintains | Overweight | |||
05/23/2025 | -11.52% | Telsey Advisory Group | $460 → $460 | Maintains | Outperform | |||
05/22/2025 | -1.9% | Canaccord Genuity | $526 → $510 | Maintains | Buy | |||
05/20/2025 | -10.56% | Oppenheimer | $435 → $465 | Maintains | Outperform | |||
05/15/2025 | -25.75% | Truist Securities | $364 → $386 | Maintains | Neutral | |||
05/14/2025 | -39.41% | Wells Fargo | $300 → $315 | Maintains | Underweight | |||
04/30/2025 | -42.29% | Wells Fargo | $310 → $300 | Maintains | Underweight | |||
04/16/2025 | -20.17% | DA Davidson | $415 → $415 | Maintains | Buy | |||
04/14/2025 | -15.37% | Baird | $460 → $440 | Maintains | Outperform | |||
04/14/2025 | — | Argus Research | — | Downgrade | Buy → Hold | |||
04/01/2025 | -18.64% | Goldman Sachs | $384 → $423 | Upgrade | Neutral → Buy | |||
03/17/2025 | -11.52% | Baird | $480 → $460 | Maintains | Outperform | |||
03/17/2025 | -29.79% | Citigroup | $405 → $365 | Maintains | Neutral | |||
03/14/2025 | -13.44% | Raymond James | $495 → $450 | Maintains | Outperform | |||
03/14/2025 | -37.1% | Barclays | $445 → $327 | Maintains | Equal-Weight | |||
03/14/2025 | 1.18% | Canaccord Genuity | $538 → $526 | Maintains | Buy | |||
03/14/2025 | -22.29% | BMO Capital | $467 → $404 | Maintains | Market Perform | |||
03/14/2025 | -20.17% | DA Davidson | $510 → $415 | Maintains | Buy | |||
03/14/2025 | -8.63% | JP Morgan | $480 → $475 | Maintains | Overweight | |||
03/14/2025 | -29.98% | Piper Sandler | $425 → $364 | Maintains | Neutral | |||
03/14/2025 | -23.06% | Stifel | $475 → $400 | Maintains | Hold | |||
03/14/2025 | -40.37% | Wells Fargo | $360 → $310 | Maintains | Underweight | |||
03/14/2025 | -36.52% | B. Riley Securities | $430 → $330 | Maintains | Neutral | |||
03/14/2025 | -26.91% | B of A Securities | $475 → $380 | Maintains | Neutral | |||
03/14/2025 | -11.52% | Telsey Advisory Group | $500 → $460 | Maintains | Outperform | |||
03/14/2025 | -11.52% | Morgan Stanley | $500 → $460 | Maintains | Overweight | |||
03/13/2025 | -10.56% | Evercore ISI Group | $490 → $465 | Maintains | Outperform | |||
03/12/2025 | -16.33% | Oppenheimer | $515 → $435 | Maintains | Outperform | |||
03/10/2025 | -3.82% | Telsey Advisory Group | $500 → $500 | Maintains | Outperform | |||
01/21/2025 | -3.82% | Morgan Stanley | $430 → $500 | Upgrade | Equal-Weight → Overweight | |||
01/09/2025 | -14.4% | Barclays | $410 → $445 | Maintains | Equal-Weight | |||
01/08/2025 | -7.67% | TD Cowen | $450 → $480 | Maintains | Hold | |||
01/07/2025 | -5.75% | Evercore ISI Group | $480 → $490 | Maintains | Outperform | |||
01/07/2025 | 3.49% | Canaccord Genuity | $500 → $538 | Maintains | Buy | |||
01/07/2025 | -12.1% | Citigroup | $450 → $457 | Maintains | Neutral | |||
01/07/2025 | -8.63% | B of A Securities | $460 → $475 | Maintains | Neutral | |||
01/07/2025 | -17.29% | B. Riley Securities | $330 → $430 | Upgrade | Sell → Neutral | |||
01/07/2025 | -8.63% | Stifel | $455 → $475 | Maintains | Hold | |||
01/07/2025 | -28.83% | Wells Fargo | $350 → $370 | Maintains | Underweight | |||
01/07/2025 | -18.25% | Piper Sandler | $394 → $425 | Maintains | Neutral | |||
01/07/2025 | -0.94% | Oppenheimer | $505 → $515 | Maintains | Outperform | |||
01/07/2025 | -3.82% | Telsey Advisory Group | $500 → $500 | Maintains | Outperform | |||
01/06/2025 | -24.21% | Piper Sandler | $390 → $394 | Maintains | Neutral | |||
12/09/2024 | -7.67% | Loop Capital | $450 → $480 | Maintains | Buy | |||
12/06/2024 | -5.75% | UBS | $470 → $490 | Maintains | Buy | |||
12/06/2024 | -13.44% | Citigroup | $390 → $450 | Maintains | Neutral | |||
12/06/2024 | -21.14% | Barclays | $335 → $410 | Maintains | Equal-Weight | |||
12/06/2024 | -1.9% | DA Davidson | $435 → $510 | Maintains | Buy | |||
12/06/2024 | -36.52% | B. Riley Securities | $300 → $330 | Maintains | Sell | |||
12/06/2024 | -19.21% | BMO Capital | $385 → $420 | Maintains | Market Perform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Ulta Beauty (ULTA)?
El último precio objetivo de Ulta Beauty (NASDAQ:ULTA) fue comunicado por Telsey Advisory Group el octubre 17, 2025. La firma de analistas fijó un precio objetivo para $610.00 que espera ULTA a rise dentro de 12 meses (un posible 17.33% upside). 100 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Ulta Beauty (ULTA)?
La última calificación de analistas para Ulta Beauty (NASDAQ:ULTA) fue proporcionada por Telsey Advisory Group, y Ulta Beauty mantuvo su outperform calificación.
¿Cuándo se produjo la última revisión al alza de Ulta Beauty (ULTA)?
La última revisión al alza de Ulta Beauty Inc se produjo en septiembre 25, 2025, cuando Argus Research elevó su precio objetivo a N/A. Argus Research anteriormente tenía a hold para Ulta Beauty Inc.
¿Cuándo fue la última revisión a la baja de Ulta Beauty (ULTA)?
La última revisión a la baja de Ulta Beauty Inc se produjo en julio 25, 2025, cuando Loop Capital cambió su precio objetivo de $510 a $510 para Ulta Beauty Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Ulta Beauty (ULTA)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Ulta Beauty, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Ulta Beauty se registró el octubre 17, 2025, por lo que la próxima calificación estará disponible en torno al octubre 17, 2026.
¿Es correcta la calificación de los analistas sobre Ulta Beauty (ULTA)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Ulta Beauty (ULTA) fue un mantuvo con un precio objetivo de $610.00 a $610.00. El precio actual al que cotiza Ulta Beauty (ULTA) es de $519.88, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.